{"organizations": [], "uuid": "077aa2d7d878691bc3a26151e90f381f73905200", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20180419&t=2&i=1253186409&w=1200&r=LYNXMPEE3I18Q", "site_section": "http://feeds.reuters.com/reuters/topNews?format=xml", "section_title": "Reuters: Top News", "url": "https://www.reuters.com/article/us-shire-m-a-allergan-exclusive/exclusive-allergan-in-talks-to-acquire-shire-competing-against-takeda-sources-idUSKBN1HQ203", "country": "US", "domain_rank": 408, "title": "Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-19T17:10:00.000+03:00", "replies_count": 0, "uuid": "077aa2d7d878691bc3a26151e90f381f73905200"}, "author": "", "url": "https://www.reuters.com/article/us-shire-m-a-allergan-exclusive/exclusive-allergan-in-talks-to-acquire-shire-competing-against-takeda-sources-idUSKBN1HQ203", "ord_in_thread": 0, "title": "Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources", "locations": [], "entities": {"persons": [{"name": "susan thomas", "sentiment": "none"}, {"name": "takeda", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "ben martin", "sentiment": "none"}, {"name": "greg roumeliotis", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}, {"name": "london", "sentiment": "none"}], "organizations": [{"name": "shire", "sentiment": "negative"}, {"name": "allergan", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "allergan plc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "takeda pharmaceutical co ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "shire plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19, 2018 / 2:09 PM / Updated an hour ago Exclusive: Allergan in talks to acquire Shire, competing against Takeda - sources Reuters Staff 1 Min Read \n(Reuters) - Botox maker Allergan Plc is in talks to acquire Shire Plc, competing against Japanâ€™s Takeda Pharmaceutical Co Ltd for the London-listed drugmaker, two sources familiar with the matter said on Thursday. The Allergan logo is seen in this photo illustration November 23, 2015. REUTERS/Thomas White/Illustration/File Photo \nIt is not clear whether Allergan has submitted an offer, and there is no certainty of a bid, the sources said. Shire on Thursday said it had rejected an offer worth around $61 billion from Takeda. \nThe sources asked not to be identified because the matter is confidential. Allergan declined to comment, while Shire and Allergan did not immediately respond to requests for comment. Reporting by Greg Roumeliotis in New York and Ben Martin in London; Editing by Susan Thomas", "external_links": [], "published": "2018-04-19T17:10:00.000+03:00", "crawled": "2018-04-19T17:24:13.028+03:00", "highlightTitle": ""}